Certara(@Certara) 's Twitter Profile Photo

It's the first day of – our inaugural client user meeting! This morning features our keynote session, a fireside chat between Dr. Scott Gottleib and Certara's CEO William Feehery!

Certainty

account_circle
Enable Medicine(@EnableMedicine) 's Twitter Profile Photo

We had a great time speaking to folks yesterday in Houston, TX about using methods and evergreen data infrastructure to tap into multimodal , surface actionable insights, and drive your and research!

We had a great time speaking to folks yesterday in Houston, TX about using #computational methods and evergreen data infrastructure to tap into multimodal #biologicaldata, surface actionable insights, and drive your #drugdevelopment and research!
account_circle
Hovione(@HovioneGroup) 's Twitter Profile Photo

Are you attending the 26th week in Tokyo? Visit us at booth No.20-16 to learn more about our integrated solutions that can support your project. Schedule a meeting hovione.com/press-room/eve… weekTokyo

Are you attending the 26th #INTERPHEX week in Tokyo? Visit us at booth No.20-16 to learn more about our integrated solutions that can support your project. Schedule a meeting hovione.com/press-room/eve… #INTERPHEXweekTokyo #drugdevelopment #drugdelivery #cdmo #initforlife
account_circle
Nicolas Girerd(@NicolasGirerd) 's Twitter Profile Photo

Our MOSAIC meeting outlined strategies for faster drug approvals by linking liver and cardiorenal targets in clinical trials. The integration of non-invasive biomarkers and imaging as trial endpoints is vital.
mosaic-nash.tmacademy.org

Our MOSAIC meeting outlined strategies for faster drug approvals by linking liver and cardiorenal targets in clinical trials. The integration of non-invasive biomarkers and imaging as trial endpoints is vital. #ClinicalTrials #DrugDevelopment 
mosaic-nash.tmacademy.org
account_circle
NIH Technology Transfer(@NIH_OTT) 's Twitter Profile Photo

Antibodies for a therapeutic to prevent hereditary hearing loss are available for licensing from the National Institute on Deafness and Other Communication Disorders

More info: go.nih.gov/cCsdnph

Antibodies for a therapeutic to prevent hereditary hearing loss are available for licensing from the National Institute on Deafness and Other Communication Disorders

More info: go.nih.gov/cCsdnph

#DrugDevelopment #DrugDiscovery #Biotechnology
account_circle
John Wilson(@johnwil07208867) 's Twitter Profile Photo

💡Ready to explore the future of ? Our team is thrilled to share our latest findings on clinical and , paving the way for transformative .
Learn more: cutt.ly/dw971NzY

💡Ready to explore the future of #clinicalresearch? Our team is thrilled to share our latest findings on clinical #research and #clinicaltrials, paving the way for transformative #patientcare. 
Learn more: cutt.ly/dw971NzY
#Healthcare #Pharmacovigilance #DrugDevelopment
account_circle
ACCELERATE(@ACCELERATE_cure) 's Twitter Profile Photo

has oficially kicked off!

Swing by our booth for a cup of tea and discover more about ACCELERATE🎗️

Don't forget to get your bookmark and watch it blosom 🌻
SIOPE 🎗️

#SIOPEurope2024 has oficially kicked off!

Swing by our booth for a cup of tea and discover more about ACCELERATE🎗️

Don't forget to get your bookmark and watch it blosom 🌻
@SIOPEurope
#ChildhoodCancer #DrugDevelopment
account_circle
Critical Path Institute (C-Path)(@CPathInstitute) 's Twitter Profile Photo

Will you be at ? Stop by C-Path’s booth #1942. For 20 yrs, has been providing the vital infrastructure to generate a unique neutral environment for those working in to collaborate. Let's find ways to advance treatments and cures TO.

Will you be at #DIA2024? Stop by C-Path’s booth #1942. For 20 yrs, #CPath has been providing the vital infrastructure to generate a unique neutral environment for those working in #drugdevelopment to collaborate. Let's find ways to advance treatments and cures TO.
account_circle
The Medicine Maker(@medicine_maker) 's Twitter Profile Photo

Introducing The Medicine Maker 2024 Power List 🏆

The nominations have been received and the decisions have been made.

Here’s our 2024 Power List of who’s helping to disrupt the status quo in pharmaceutical and .
bit.ly/4ap2m3j

Introducing The Medicine Maker 2024 Power List 🏆

The nominations have been received and the decisions have been made.

Here’s our 2024 Power List of who’s helping to disrupt the status quo in pharmaceutical #drugdevelopment and #manufacturing. 
bit.ly/4ap2m3j

#pharma
account_circle
PathAI(@Path_AI) 's Twitter Profile Photo

Today, we shared our pre-print describing our new PLUTO (PathoLogy Universal TransfOrmer) to fuel & for fast, efficient and powerful representation of images

Read the Paper: arxiv.org/abs/2405.07905

account_circle
Egle Pavyde(@eglepavyde) 's Twitter Profile Photo

Asia BIO ✅ ESCMID European Society of Clinical Microbiology & Infectious Diseases Congress in progress 🦠🔄 Representing hVIVO together with Nicolas, will keep you posted on highlights!

Asia BIO ✅ @ESCMID European Society of Clinical Microbiology & Infectious Diseases Congress in progress 🦠🔄 Representing @hVIVO_UK together with Nicolas, will keep you posted on highlights!
#infectiousdiseases #drugdevelopment #clinicalresearch #hvo #escmid #ESCMIDGlobal2024
account_circle
UNITE4TB(@UNITE4TB) 's Twitter Profile Photo

Our pre-lunch session included 2 presentations: The first on model-informed by UNITE4TB's Elin Svensson (@radboudumc) & ERA4TB's Oscar della Pasqua (@CNRsocial_).

Our pre-lunch session included 2 presentations: The first on model-informed #drugdevelopment by UNITE4TB's @elinmasv (@radboudumc) & ERA4TB's Oscar della Pasqua (@CNRsocial_).
account_circle
UNITE4TB(@UNITE4TB) 's Twitter Profile Photo

Post-lunch, we turn our focus to with a session on public participation and input along the pipeline. The session is chaired by ERA4TB Project 's Katharine Cresswell, (@NICEcomms) & UNITE4TB's Pippa Powell (@EuropeanLung).

Post-lunch, we turn our focus to #CommunityEngagement with a session on public participation and input along the #drugdevelopment   pipeline. The session is chaired by @IMI_ERA4TB 's Katharine Cresswell, (@NICEcomms) & @UNITE4TB's Pippa Powell (@EuropeanLung).
account_circle
Unlearn.AI(@UnlearnAI) 's Twitter Profile Photo

In this BIOS interview, our founder and CEO, Charles Fisher, discusses digital twins and their impact on .⚕️

Learn more about how we use in here: unlearn.ai/twinrcts

account_circle
Institute for Drug & Biotherapeutic Innovation(@slu_idbi) 's Twitter Profile Photo

Congratulations to @GarkKoyal and her former students on securing funding for continued development of treatments for Volumetric Muscle Loss!

account_circle